120 related articles for article (PubMed ID: 31246148)
1. Clinical features and cell of origin subtyping using gene expression profiling in HIV-negative patients with primary central nervous system lymphoma.
Hilal T; Maguire A; Kosiorek HE; Rimsza LM; Rosenthal AC
Leuk Lymphoma; 2019 Dec; 60(14):3581-3583. PubMed ID: 31246148
[No Abstract] [Full Text] [Related]
2. Promoter methylation attenuates SHP1 expression and function in patients with primary central nervous system lymphoma.
Liu J; Wang Y; Sun X; Ji N; Sun S; Wang Y; Liu F; Cui Q; Wang C; Liu Y
Oncol Rep; 2017 Feb; 37(2):887-894. PubMed ID: 27959415
[TBL] [Abstract][Full Text] [Related]
3. Treatment of HIV-associated primary CNS lymphoma with antiretroviral therapy, rituximab, and high-dose methotrexate.
Lurain K; Uldrick TS; Ramaswami R; Polizzotto MN; Goncalves PH; Widell A; Steinberg SM; Jaffe ES; Pittaluga S; Wang HW; Yuan CM; Tamula MA; Martin S; Wolters PL; George J; Little RF; Yarchoan R
Blood; 2020 Nov; 136(19):2229-2232. PubMed ID: 32609814
[No Abstract] [Full Text] [Related]
4. Survival prediction based on the gene expression associated with cancer morphology and microenvironment in primary central nervous system lymphoma.
Takashima Y; Kawaguchi A; Fukai J; Iwadate Y; Kajiwara K; Hondoh H; Yamanaka R
PLoS One; 2021; 16(6):e0251272. PubMed ID: 34166375
[TBL] [Abstract][Full Text] [Related]
5. Hyperglycemia is associated with poor survival in primary central nervous system lymphoma patients.
Debata A; Yoshida K; Ujifuku K; Yasui H; Kamada K; Niino D; Matsuo T
Tumori; 2017 May; 103(3):272-278. PubMed ID: 28058711
[TBL] [Abstract][Full Text] [Related]
6. Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma. The Massachusetts General Hospital experience 1958-1989.
Miller DC; Hochberg FH; Harris NL; Gruber ML; Louis DN; Cohen H
Cancer; 1994 Aug; 74(4):1383-97. PubMed ID: 8055462
[TBL] [Abstract][Full Text] [Related]
7. Comparison of circulating tumor DNA between body fluids in patients with primary central nervous system lymphoma.
Watanabe J; Natsumeda M; Kanemaru Y; Okada M; Oishi M; Kakita A; Fujii Y
Leuk Lymphoma; 2019 Dec; 60(14):3587-3589. PubMed ID: 31305194
[No Abstract] [Full Text] [Related]
8. Toward methylation-based classification of central nervous system tumors.
Hegi ME; Kleihues P; Wen PY; Suvà ML
Neuro Oncol; 2018 Apr; 20(5):579-581. PubMed ID: 29584921
[No Abstract] [Full Text] [Related]
9. Analysis of immunoglobulin H gene rearrangement by polymerase chain reaction in primary central nervous system lymphoma.
Kros JM; Bagdi EK; Zheng P; Hop WC; Driesse MJ; Krenacs L; Dinjens WN
J Neurosurg; 2002 Dec; 97(6):1390-6. PubMed ID: 12507138
[TBL] [Abstract][Full Text] [Related]
10. Management and prognosis of 66 patients with B-cell non-Hodgkin lymphoma presenting with initial spinal cord compression: a French retrospective multicenter study.
Fleury I; Amorim S; Mounier N; Coiffier B; Dupuis J; Tilly H; Mazari MA; Filliatre L; Brière J; Brice P; de Kerviler E; Thieblemont C
Leuk Lymphoma; 2015 Jul; 56(7):2025-31. PubMed ID: 25347431
[TBL] [Abstract][Full Text] [Related]
11. Insights into the biology of primary central nervous system lymphoma.
Mrugala MM; Rubenstein JL; Ponzoni M; Batchelor TT
Curr Oncol Rep; 2009 Jan; 11(1):73-80. PubMed ID: 19080745
[TBL] [Abstract][Full Text] [Related]
12. Testicular relapse of primary central nervous system lymphoma.
Rajappa SJ; Uppin SG; Digumarti R
Leuk Lymphoma; 2007 May; 48(5):1023-5. PubMed ID: 17487747
[No Abstract] [Full Text] [Related]
13. Differential expression of N-linked oligosaccharides in methotrexate-resistant primary central nervous system lymphoma cells.
Takashima Y; Yoshimura T; Kano Y; Hayano A; Hondoh H; Ikenaka K; Yamanaka R
BMC Cancer; 2019 Sep; 19(1):910. PubMed ID: 31510952
[TBL] [Abstract][Full Text] [Related]
14. Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report.
Grimm SA; Pulido JS; Jahnke K; Schiff D; Hall AJ; Shenkier TN; Siegal T; Doolittle ND; Batchelor T; Herrlinger U; Neuwelt EA; Laperriere N; Chamberlain MC; Blay JY; Ferreri AJ; Omuro AM; Thiel E; Abrey LE
Ann Oncol; 2007 Nov; 18(11):1851-5. PubMed ID: 17804469
[TBL] [Abstract][Full Text] [Related]
15. Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma.
Landsburg DJ; Petrich AM; Abramson JS; Sohani AR; Press O; Cassaday R; Chavez JC; Song K; Zelenetz AD; Gandhi M; Shah N; Fenske TS; Jaso J; Medeiros LJ; Yang DT; Nabhan C
Cancer; 2016 Feb; 122(4):559-64. PubMed ID: 26565895
[TBL] [Abstract][Full Text] [Related]
16. Pathology and genetics of primary central nervous system and intraocular lymphoma.
Rubenstein JL; Treseler P; O'Brien JM
Hematol Oncol Clin North Am; 2005 Aug; 19(4):705-17, vii. PubMed ID: 16083831
[TBL] [Abstract][Full Text] [Related]
17. Primary central nervous system lymphoma.
DeAngelis LM
Recent Results Cancer Res; 1994; 135():155-69. PubMed ID: 8047690
[No Abstract] [Full Text] [Related]
18. EZH2 mutations in follicular lymphoma from different ethnic groups and associated gene expression alterations.
Guo S; Chan JK; Iqbal J; McKeithan T; Fu K; Meng B; Pan Y; Cheuk W; Luo D; Wang R; Zhang W; Greiner TC; Chan WC
Clin Cancer Res; 2014 Jun; 20(12):3078-86. PubMed ID: 24634383
[TBL] [Abstract][Full Text] [Related]
19. AIDS-related non-Hodgkin lymphoma: imaging feature analysis of 27 cases and correlation with pathologic findings.
Yang J; Wang P; Lv ZB; Wei LG; Xu YL; Zhou A; Xu DH; Ma DQ
Asian Pac J Cancer Prev; 2014; 15(18):7769-73. PubMed ID: 25292061
[TBL] [Abstract][Full Text] [Related]
20. Primary central nervous system lymphoma with testicular metastasis.
Liu XJ; Zhao JZ; Li G; Ye X; Yan PX
Clin Neurol Neurosurg; 2012 Jan; 114(1):80-3. PubMed ID: 21871714
[No Abstract] [Full Text] [Related]
[Next] [New Search]
